This session reports on the successes and failures experienced during the implementation of a graduate-level Certificate in Technology Entrepreneurship program. The two-year program on commercializing technology was launched in 2008 and is jointly delivered by the University of Portland (UP) and Oregon Health & Science University (OHSU). The innovative courses developed for the program have been approved by the OHSU School of Medicine Graduate Council and UP. Only five students are accepted to join the program each year from each institution. One of the stated program objectives is to start new companies or secure technology licensing deals. Attendees of this session will learn about the design of this novel program and hear directly from one or more students in the program about their experiences.

1. Robin Anderson
Jon Down
Peter Rachor
University of Portland

5. ViTi, Inc. (TB-8):
An exploration of the path to launching a university
biotechnology spinoff and commercializing their lead technology:
a technique for diagnosing tuberculosis in young children.
Resorbable Brain Stent to Treat Hydrocephalus;
A novel resorbable brain stent designed to increase
the success rate of surgery to correct the rare disorder known as
hy-drocephalus, or water on the brain.
APDM – Integrated Solution Targeting Movement
Disorders, Specifically Parkinson’s:
APDM ’s OPAL allows for real-time non-invasive
monitoring of movements of individuals with Parkinson’s and
other movement disorders.